Oncocyte Corporation - Common Stock (OCX)
2.7000
-0.2200 (-7.53%)
NASDAQ · Last Trade: Apr 6th, 4:40 PM EDT
Via Benzinga · April 1, 2025
Via Benzinga · March 26, 2025

OCX stock results show that OncoCyte beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024

OncoCyte's Innovative Approach: Potential in Precision Diagnostics
Via News Direct · June 5, 2024

OCX stock results show that OncoCyte missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 15, 2024

Via Benzinga · April 23, 2024

We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!
Via InvestorPlace · April 15, 2024

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.
Via Benzinga · April 15, 2024

Shares of Medical Properties Trust, Inc. (NYSE: MPW) rose sharply in today’s pre-market trading after the company announced that it sold its majority interest in Utah Hospitals.
Via Benzinga · April 15, 2024

Via Benzinga · April 12, 2024

OCX stock results show that OncoCyte missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · April 12, 2024

As of April 12, 2024, three stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via Benzinga · April 12, 2024

Friday is here and we're starting the final day of trading this week with a breakdown of the biggest pre-market stock movers this morning!
Via InvestorPlace · April 12, 2024

Companies Reporting Before The Bell • Progressive (NYSE:PGR) is projected to report quarterly earnings at $3.17 per share on revenue of $17.43 billion.
Via Benzinga · April 12, 2024

Shares of NextPlat Corp (NASDAQ: NXPL) rose sharply in today’s pre-market trading after the company reported consolidated 2023 revenues of $37.8 million, up 222% year over year
Via Benzinga · April 12, 2024

Via Benzinga · November 9, 2023

Via Benzinga · November 9, 2023

Gainers Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares climbed 83.5% to $0.4169 after reporting first-quarter results.
Via Benzinga · November 9, 2023

Gainers Abri SPAC I, Inc. (NASDAQ: ASPA) shares climbed 127.1% to $28.39. Abri's stockholders approved its proposed business combination with DLQ.
Via Benzinga · October 25, 2023

Companies Reporting Before The Bell • IDEX Biometrics (NASDAQ:IDBA) is estimated to report quarterly loss at $0.39 per share on revenue of $1.60 million.
Via Benzinga · August 10, 2023